Keros Therapeutics, Inc. (KROS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Keros Therapeutics, Inc. on June 7, 2023. The report serves as a Regulation FD disclosure regarding an upcoming corporate presentation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a specific event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled presentation by company leadership.
Guidance, Outlook, and Management Commentary
On June 7, 2023, the Company announced that Jasbir Seehra, President and Chief Executive Officer, will present at Goldman Sachs' 44th Annual Health Care Conference. The presentation is scheduled for Wednesday, June 14, 2023, at 11:40 a.m. Eastern time. The accompanying press release is included as Exhibit 99.1.
Key Facts for Investor Verification
- CEO Jasbir Seehra is scheduled to present at the Goldman Sachs 44th Annual Health Care Conference on June 14, 2023.
- The filing contains no financial data; investors should refer to the most recent 10-K or 10-Q for financial metrics.
- The information in this report is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.